Literature DB >> 22479070

Phenytoin-induced reduction in sirolimus levels.

Duane Bates1, Kelly W Burak, Carla S Coffin, Tammy Ying, Echo-Marie Enns.   

Abstract

Entities:  

Year:  2011        PMID： 22479070      PMCID： PMC3161802          DOI： 10.4212/cjhp.v64i4.1040

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  8 in total

1.  Use of rapamycin in a transplant patient who developed cyclosporin neurotoxicity.

Authors:  C B Hodges; H Maxwell; T J Beattie; A V Murphy; R M Jindal
Journal:  Pediatr Nephrol       Date:  2001-10       Impact factor: 3.714

2.  Proposal for a new tool to evaluate drug interaction cases.

Authors:  John R Horn; Philip D Hansten; Lingtak-Neander Chan
Journal:  Ann Pharmacother       Date:  2007-03-27       Impact factor: 3.154

Review 3.  Antiepileptic drug interactions.

Authors:  Rosa Ana Saiz Díaz; Jerónimo Sancho; José Serratosa
Journal:  Neurologist       Date:  2008-11       Impact factor: 1.398

Review 4.  Altered cytochrome p450 metabolism of calcineurin inhibitors: case report and review of the literature.

Authors:  Christine M Formea; Christopher G Evans; Janet L Karlix
Journal:  Pharmacotherapy       Date:  2005-07       Impact factor: 4.705

5.  Exposure-response relationships and drug interactions of sirolimus.

Authors:  James J Zimmerman
Journal:  AAPS J       Date:  2004-10-15       Impact factor: 4.009

Review 6.  Use of sirolimus in solid organ transplantation.

Authors:  Joshua J Augustine; Kenneth A Bodziak; Donald E Hricik
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Phenytoin decreases the blood concentrations of sirolimus in a liver transplant recipient: a case report.

Authors:  Jonathan A Fridell; Ashok Kumar B Jain; Kusum Patel; Mohamed Virji; K N Rao; John J Fung; Raman Venkataramanan
Journal:  Ther Drug Monit       Date:  2003-02       Impact factor: 3.681

Review 8.  Epilepsy in later life.

Authors:  Martin J Brodie; Andrew T Elder; Patrick Kwan
Journal:  Lancet Neurol       Date:  2009-10-01       Impact factor: 44.182
  8 in total
  1 in total

1.  Venous thromboembolism due to suspected interaction between rivaroxaban and nevirapine.

Authors:  Duane Bates; Bruce Dalton; Janet Gilmour; Jeff Kapler
Journal:  Can J Hosp Pharm       Date:  2013-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.